Agilent Technologies (NYSE:A) issues FY2024 earnings guidance

Agilent Technologies (NYSE:A – Get Your Free Report ) issued an update on its FY2024 earnings guidance on Wednesday morning. The company provided an EPS estimate of 5,210-5,250 for the period, compared to the consensus EPS estimate of 5,200. The company issued a revenue estimate of $6.5 billion – $6.5 billion, compared to the consensus revenue estimate of $6.5 billion. Agilent Technologies also upgraded its guidance for Q4 to $1.38-$1.42 EPS.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock traded up $1.77 during trading on Thursday, reaching $141.76. The stock had a trading volume of 394,979 shares, compared to its average volume of 1,744,436. The company has a fifty day moving average of $133.75 and a two hundred day moving average of $138.48. The firm has a market cap of $41.36 billion, a P/E ratio of 33.08, a PEG ratio of 4.86 and a beta of 1.05. Agilent Technologies has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15, and a quick ratio of 1.64.

Agilent Technologies (NYSE:A – Get Your Free Report ) last posted its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. In the same quarter last year, the company earned $1.43 per share. The company’s revenue fell 5.6% year over year. On average, sell-side analysts expect that Agilent Technologies will post 5.24 earnings per share for the current fiscal year.

Analysts set new price targets

Several brokerages recently weighed in on A. Evercore ISI upped their target price on Agilent Technologies from $130.00 to $135.00 and gave the company an in-line rating in a research note on Thursday . UBS Group reduced their price objective on shares of Agilent Technologies from $155.00 to $141.00 and set a neutral rating for the company in a research report on Thursday, May 30th. TD Cowen reissued a buy rating and issued a $153.00 price target on shares of Agilent Technologies in a research note on Monday, July 29th. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $155.00 and set an overweight rating for the company in a report on Thursday, May 30th. Finally, Stifel Nicolaus cut their price target on shares of Agilent Technologies from $163.00 to $151.00 and set a buy rating on the stock in a research report on Thursday, May 30th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. Agilent Technologies has a consensus rating of Moderate Buy and an average price target of $138.07, according to MarketBeat.com.

Get the latest report on A

Indoor activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640. The transaction was disclosed in a filing with the SEC, which is available on the SEC’s website. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the sale, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the transaction, the chief executive officer now owns 26,076 shares of the company’s stock, valued at $3,650,640. The disclosure for this sale can be found here. Insiders sold 18,916 shares of company stock worth $2,527,860 in the last quarter. 0.33% of shares are currently owned by company insiders.

Agilent Technologies Company Profile

(Get a free report)

Agilent Technologies, Inc provides application-focused solutions to the life sciences, diagnostics and applied chemistry markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; mass spectrometry systems for liquid chromatography; systems and components for gas chromatography; mass spectrometry systems for gas chromatography; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; spectroscopy remain; cell assay plate assays; flow cytometer; real-time cell analyzer; cellular imaging systems; microplate reader; laboratory software; information management and analysis; laboratory automation and robotic systems; dissolution testing; and vacuum pumps and measurement technologies.

Featured stories

Get daily news and reviews for Agilent Technologies – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.